| Literature DB >> 24996404 |
Kathrin Koch1, Nicholas E Myers2, Jens Göttler1, Lorenzo Pasquini1, Timo Grimmer3, Stefan Förster4, Andrei Manoliu5, Julia Neitzel6, Alexander Kurz3, Hans Förstl3, Valentin Riedl7, Afra M Wohlschläger8, Alexander Drzezga9, Christian Sorg10.
Abstract
Amyloid-β pathology (Aβ) and impaired cognition characterize Alzheimer's disease (AD); however, neural mechanisms that link Aβ-pathology with impaired cognition are incompletely understood. Large-scale intrinsic connectivity networks (ICNs) are potential candidates for this link: Aβ-pathology affects specific networks in early AD, these networks show disrupted connectivity, and they process specific cognitive functions impaired in AD, like memory or attention. We hypothesized that, in AD, regional changes of ICNs, which persist across rest- and cognitive task-states, might link Aβ-pathology with impaired cognition via impaired intrinsic connectivity. Pittsburgh compound B (PiB)-positron emission tomography reflecting in vivo Aβ-pathology, resting-state fMRI, task-fMRI, and cognitive testing were used in patients with prodromal AD and healthy controls. In patients, default mode network's (DMN) functional connectivity (FC) was reduced in the medial parietal cortex during rest relative to healthy controls, relatively increased in the same region during an attention-demanding task, and associated with patients' cognitive impairment. Local PiB-uptake correlated negatively with DMN connectivity. Importantly, corresponding results were found for the right lateral parietal region of an attentional network. Finally, structural equation modeling confirmed a direct influence of DMN resting-state FC on the association between Aβ-pathology and cognitive impairment. Data provide evidence that disrupted intrinsic network connectivity links Aβ-pathology with cognitive impairment in early AD.Entities:
Keywords: PiB-PET; amyloid plaques; impaired cognition; intrinsic connectivity networks; prodromal Alzheimer's disease; resting-state fMRI; task-fMRI
Mesh:
Substances:
Year: 2014 PMID: 24996404 PMCID: PMC4635914 DOI: 10.1093/cercor/bhu151
Source DB: PubMed Journal: Cereb Cortex ISSN: 1047-3211 Impact factor: 5.357